Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Idiopathic Pulmonary Fibrosis | 18 | 2024 | 520 | 4.340 |
Why?
|
Lung Diseases, Interstitial | 19 | 2024 | 945 | 4.100 |
Why?
|
Scleroderma, Systemic | 9 | 2024 | 349 | 2.210 |
Why?
|
Pulmonary Fibrosis | 6 | 2023 | 506 | 1.550 |
Why?
|
Collagen Type I | 3 | 2023 | 620 | 1.210 |
Why?
|
Molecular Imaging | 5 | 2023 | 827 | 1.090 |
Why?
|
Gallium Radioisotopes | 3 | 2023 | 195 | 0.990 |
Why?
|
Continuous Positive Airway Pressure | 6 | 2014 | 579 | 0.840 |
Why?
|
Lung | 20 | 2024 | 10089 | 0.820 |
Why?
|
Fibrosis | 8 | 2023 | 2077 | 0.660 |
Why?
|
Sleep Apnea, Obstructive | 5 | 2014 | 1891 | 0.590 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 359 | 0.560 |
Why?
|
Dyspnea | 4 | 2024 | 1351 | 0.500 |
Why?
|
Autoantibodies | 3 | 2020 | 2126 | 0.470 |
Why?
|
Organometallic Compounds | 1 | 2018 | 648 | 0.470 |
Why?
|
Bronchiolitis Obliterans | 1 | 2016 | 220 | 0.470 |
Why?
|
Collagen | 2 | 2023 | 2646 | 0.440 |
Why?
|
Positron-Emission Tomography | 5 | 2024 | 6670 | 0.430 |
Why?
|
Gadolinium | 1 | 2018 | 965 | 0.420 |
Why?
|
Lysophospholipids | 2 | 2022 | 338 | 0.420 |
Why?
|
Sleep Apnea, Central | 1 | 2013 | 88 | 0.410 |
Why?
|
Masks | 1 | 2013 | 214 | 0.370 |
Why?
|
Pneumonia | 1 | 2023 | 2163 | 0.370 |
Why?
|
Vascular Diseases | 1 | 2018 | 1161 | 0.330 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1597 | 0.330 |
Why?
|
Biomedical Research | 1 | 2024 | 3464 | 0.300 |
Why?
|
Capillary Permeability | 2 | 2022 | 773 | 0.290 |
Why?
|
Autoantigens | 2 | 2020 | 891 | 0.240 |
Why?
|
Humans | 56 | 2024 | 768393 | 0.230 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2023 | 23 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 7 | 2023 | 36849 | 0.230 |
Why?
|
Models, Biological | 1 | 2019 | 9493 | 0.200 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2024 | 325 | 0.200 |
Why?
|
Lung Injury | 2 | 2024 | 433 | 0.200 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2022 | 78 | 0.200 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13576 | 0.190 |
Why?
|
Fibrin | 1 | 2024 | 514 | 0.190 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2023 | 234 | 0.160 |
Why?
|
Pseudomonas Infections | 1 | 2023 | 623 | 0.160 |
Why?
|
Research Subjects | 1 | 2021 | 249 | 0.160 |
Why?
|
Tissue Distribution | 1 | 2022 | 2299 | 0.150 |
Why?
|
Indoles | 2 | 2024 | 1825 | 0.150 |
Why?
|
Critical Care | 2 | 2021 | 2716 | 0.150 |
Why?
|
Ephrin-B2 | 1 | 2017 | 40 | 0.150 |
Why?
|
Blood Pressure | 2 | 2014 | 8541 | 0.150 |
Why?
|
Receptors, Chemokine | 1 | 2021 | 652 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 7 | 2021 | 20765 | 0.140 |
Why?
|
Radiometry | 1 | 2022 | 817 | 0.140 |
Why?
|
Molecular Probes | 1 | 2018 | 309 | 0.140 |
Why?
|
Lung Diseases | 2 | 2019 | 1925 | 0.140 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15939 | 0.130 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 4411 | 0.130 |
Why?
|
Galectin 3 | 1 | 2018 | 240 | 0.130 |
Why?
|
Radiation Injuries | 1 | 2023 | 1204 | 0.130 |
Why?
|
Sepsis | 2 | 2021 | 2601 | 0.130 |
Why?
|
Myofibroblasts | 1 | 2017 | 229 | 0.130 |
Why?
|
Biopsy | 3 | 2022 | 6808 | 0.130 |
Why?
|
Bronchiectasis | 1 | 2016 | 139 | 0.120 |
Why?
|
Plasma Cells | 1 | 2018 | 599 | 0.120 |
Why?
|
Fibroblasts | 2 | 2023 | 4177 | 0.120 |
Why?
|
Obesity Hypoventilation Syndrome | 1 | 2014 | 17 | 0.120 |
Why?
|
Immunosuppressive Agents | 5 | 2024 | 4209 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2024 | 10377 | 0.110 |
Why?
|
Cyclophosphamide | 3 | 2024 | 2226 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1627 | 0.110 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2017 | 614 | 0.110 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1795 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1335 | 0.100 |
Why?
|
Shock, Septic | 1 | 2019 | 774 | 0.100 |
Why?
|
Prone Position | 1 | 2014 | 203 | 0.100 |
Why?
|
Breath Tests | 1 | 2014 | 300 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2019 | 22296 | 0.100 |
Why?
|
Female | 18 | 2024 | 397089 | 0.100 |
Why?
|
Male | 18 | 2024 | 364902 | 0.100 |
Why?
|
Endothelial Cells | 2 | 2022 | 3587 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1367 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1241 | 0.100 |
Why?
|
Tidal Volume | 1 | 2014 | 515 | 0.090 |
Why?
|
Aged | 11 | 2024 | 171562 | 0.090 |
Why?
|
Patient Positioning | 1 | 2014 | 332 | 0.090 |
Why?
|
Forced Expiratory Volume | 1 | 2016 | 1820 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1014 | 0.090 |
Why?
|
Critical Illness | 2 | 2021 | 2755 | 0.090 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 1468 | 0.090 |
Why?
|
Disease Progression | 5 | 2024 | 13646 | 0.080 |
Why?
|
Antigens, CD | 1 | 2020 | 4031 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1671 | 0.080 |
Why?
|
Middle Aged | 12 | 2024 | 223491 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1084 | 0.080 |
Why?
|
Autonomic Nervous System | 1 | 2014 | 709 | 0.080 |
Why?
|
Prognosis | 3 | 2023 | 30022 | 0.080 |
Why?
|
Contrast Media | 2 | 2020 | 5336 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2021 | 59686 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2661 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2024 | 81801 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7453 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2016 | 1309 | 0.070 |
Why?
|
Polysomnography | 1 | 2013 | 1865 | 0.070 |
Why?
|
United States | 3 | 2024 | 73150 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2019 | 3801 | 0.060 |
Why?
|
Quality of Life | 5 | 2024 | 13503 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13020 | 0.060 |
Why?
|
Risk Factors | 3 | 2024 | 74962 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9516 | 0.060 |
Why?
|
Skin | 1 | 2017 | 4499 | 0.060 |
Why?
|
Bariatric Surgery | 1 | 2014 | 1013 | 0.060 |
Why?
|
Bronchoalveolar Lavage | 1 | 2023 | 131 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2014 | 2721 | 0.050 |
Why?
|
Heart Rate | 1 | 2014 | 4218 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 263 | 0.050 |
Why?
|
Mycophenolic Acid | 1 | 2024 | 350 | 0.050 |
Why?
|
Animals | 7 | 2023 | 169337 | 0.050 |
Why?
|
Vital Capacity | 1 | 2024 | 984 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 294 | 0.040 |
Why?
|
Bleomycin | 1 | 2022 | 493 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2017 | 7880 | 0.040 |
Why?
|
Hypertrophy | 1 | 2022 | 562 | 0.040 |
Why?
|
Therapeutic Equipoise | 1 | 2019 | 29 | 0.040 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 32 | 0.040 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2019 | 30 | 0.040 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2021 | 199 | 0.040 |
Why?
|
Sphingosine | 1 | 2022 | 308 | 0.040 |
Why?
|
Peroxidase | 1 | 2023 | 609 | 0.040 |
Why?
|
Exoribonucleases | 1 | 2019 | 88 | 0.040 |
Why?
|
Mucin-5B | 1 | 2019 | 148 | 0.040 |
Why?
|
Telomere-Binding Proteins | 1 | 2019 | 121 | 0.040 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2019 | 62 | 0.040 |
Why?
|
Immunosorbent Techniques | 1 | 2018 | 174 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 60049 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 65379 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39407 | 0.040 |
Why?
|
Electroencephalography | 1 | 2013 | 6317 | 0.040 |
Why?
|
Mice | 5 | 2023 | 82017 | 0.040 |
Why?
|
Hemoptysis | 1 | 2019 | 152 | 0.040 |
Why?
|
Proton Pump Inhibitors | 1 | 2022 | 553 | 0.040 |
Why?
|
Sample Size | 1 | 2020 | 848 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4570 | 0.030 |
Why?
|
Cohort Studies | 1 | 2019 | 41795 | 0.030 |
Why?
|
Adult | 6 | 2021 | 223640 | 0.030 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 471 | 0.030 |
Why?
|
Exocytosis | 1 | 2017 | 323 | 0.030 |
Why?
|
Matrix Metalloproteinases | 1 | 2018 | 393 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2019 | 567 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20224 | 0.030 |
Why?
|
Sex Distribution | 1 | 2021 | 2281 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2022 | 1161 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 585 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11858 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 855 | 0.030 |
Why?
|
Resuscitation | 1 | 2019 | 679 | 0.030 |
Why?
|
Observer Variation | 1 | 2021 | 2623 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 2003 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 752 | 0.030 |
Why?
|
Gene Deletion | 1 | 2022 | 2673 | 0.030 |
Why?
|
Integrins | 1 | 2018 | 843 | 0.030 |
Why?
|
DNA Helicases | 1 | 2019 | 853 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8615 | 0.030 |
Why?
|
Pyridones | 1 | 2019 | 818 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1141 | 0.030 |
Why?
|
Sarcoidosis | 1 | 2019 | 534 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54920 | 0.030 |
Why?
|
Supine Position | 1 | 2014 | 208 | 0.030 |
Why?
|
Respiration | 1 | 2020 | 1667 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18362 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 9063 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1320 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3211 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2018 | 1506 | 0.020 |
Why?
|
Protein Transport | 1 | 2017 | 1958 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3431 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2022 | 22355 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14737 | 0.020 |
Why?
|
Artifacts | 1 | 2020 | 1930 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2201 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2533 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4646 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2726 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9562 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4936 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3960 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6510 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6210 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4775 | 0.020 |
Why?
|
Remission Induction | 1 | 2014 | 2407 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5801 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5496 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3666 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4076 | 0.020 |
Why?
|
Stroke Volume | 1 | 2019 | 5619 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7463 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8051 | 0.010 |
Why?
|
Acute Disease | 1 | 2015 | 7242 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15455 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13323 | 0.010 |
Why?
|
Genetic Variation | 1 | 2019 | 6606 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16721 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10478 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14481 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8562 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19022 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9682 | 0.010 |
Why?
|
Obesity | 2 | 2014 | 13084 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6409 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8731 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12778 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3243 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18048 | 0.010 |
Why?
|
Adolescent | 1 | 2014 | 89184 | 0.000 |
Why?
|
Neoplasms | 1 | 2013 | 22385 | 0.000 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(86)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_